Facebook
Twitter
LinkedIn
Forward
Obesity and COVID-19 in the Outpatient Setting: What Clinicians Need to Know
Multiple studies have demonstrated that patients with obesity are at increased risk for more severe COVID-19 disease. Physiological, anatomical, and psychological factors underly this increased risk and should be considered as patients with obesity are counseled about preventing SARS-CoV-2 infection and during the management of those who have COVID-19. Fortunately, guidance is being developed by the European Association for the Study of Obesity (EASO). In particular, the EASO recommends that clinicians continue to implement obesity management strategies despite social distancing or quarantine. COVID-19 is a new disease and the understanding of its pathophysiology and treatment continues to evolve. In addition to information about managing patients with obesity, clinicians need to remain current to understand how recommended therapies work and optimize their use as they become available.
The program, “Obesity and COVID-19 in the Outpatient Setting: What Clinicians Need to Know,” will provide information that clinicians require to appropriately advise patients with obesity on how to avoid infection, monitor their patients with obesity who develop COVID-19, and recognize and manage complications as they occur to minimize morbidity and mortality.
Target Audience
The intended audience for this educational initiative is clinicians responsible for the daily management of patients with obesity.
Learning Objectives
The proposed initiative is designed to address ACGME and NAM competencies, including delivering patient-centered care and practicing evidence-based medicine.
This program is designed to address ACPE competencies, including foundational knowledge, essentials for practice and care, and approaches to practice and care.
At the conclusion of this education, participants should be able to:
- Discuss the most current understanding of the pathophysiology of COVID-19
- Describe factors that increase the risks of COVID-19 for patients with obesity
- Develop strategies for individualized management of patients with obesity during the COVID-19 pandemic
- Provide counsel to patients with obesity regarding concerns or fears related to COVID-19
Additional Information
J. Morgan Freiman, MD, MSc
Infectious Diseases Physician
Director of Antimicrobial Stewardship
Lahey Hospital and Medical Center
Assistant Professor of Medicine
Tufts University School of Medicine
Boston, MA
J. Morgan Freiman, MD, MSc is an Infectious Diseases physician and the Director for the Antimicrobial Stewardship Program at Lahey Hospital and Medical Center in Burlington, MA. She trained in infectious diseases and epidemiology at Boston Medical Center and Boston University School of Public Health, prior to joining the faculty at Tufts Medical School. She worked on the front lines during the COVID-19 pandemic providing care for hundreds of patients and lead a multi-disciplinary committee to create and implement treatment guidelines for her home institution.
Ted Kyle, RPh, MBA
Founder, ConscienHealth
Pittsburgh, PA
Ted Kyle, RPh, MBA founded ConscienHealth in 2009. Ted is a pharmacist and healthcare innovation professional who works with health and obesity experts for sound policy and innovation to address obesity. He serves on the Board of Directors for the Obesity Action Coalition, advises The Obesity Society on advocacy, and consults with organizations addressing the needs of people living with obesity. His widely-read daily commentary, published at conscienhealth.org/news, reaches an audience of more than 10,000 thought leaders in health and obesity. His peer-reviewed publications focus upon weight bias and policy related to health and obesity.
Donna H. Ryan, MD
Professor Emerita
Pennington Biomedical Research Center
New Orleans, LA
Donna H. Ryan, MD is Professor Emerita at Pennington Biomedical in Baton Rouge, LA, and current President of World Obesity Federation. She is Associate Editor-in-Chief of the journal Obesity and has authored more than 200 publications, primarily on obesity. Dr. Ryan’s research focuses on nutrition, obesity and obesity comorbidities. She has been an investigator for various US National Institutes of Health-sponsored studies, including Pounds Lost, DASH (Dietary Approaches to Stop Hypertension), DPP (Diabetes Prevention Program) and the Look AHEAD study. Dr. Ryan’s continuing interests focus on translation of effective weight management into primary care practices. Dr. Ryan served as Co-Chair on the expert panel for the 2013 ACC/AHA/TOS evidence-based Guidelines on the Evaluation and Management of Overweight and Obesity in Adults and was a panel member of the 2015 Endocrine Society Systematic Evidence Review and Guidelines for Medications that Affect Body Weight. She is Co-Chair of the Steering Committee SELECT, a cardiovascular outcome trial of semaglutide.
Bridget M. Slusarek, RN, BSN, MBA
Registered Nurse
Forest Lake, MN
Bridget M. Slusarek, RN, BSN, MBA is a registered nurse and for the past 16 years has been a nurse influencer, educator, and leader in the areas of chronic disease and population health issues including obesity, nephrology, and gastrointestinal disease. She is a graduate of University of Wisconsin Oshkosh School of Nursing and obtained her MBA from the College of Saint Scholastica. She has been a course director for the Bariatric Education Days CME event for the past several years and has been on the planning committee for the past 15 years. She has worked as a Nurse Coordinator, Nurse Manager, System Director and Service Line Director for M Health Fairview. Bridget was a past American Bariatric Society of Metabolic Surgery (ASMBS) Minnesota State Secretary and is currently on a national committee for the Access to Care Committee for ASMBS. She is passionate about promoting Health and Wellness and is certified as an Intrinsic Health Coach.
DISCLOSURE INFORMATION
The Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.
All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.
Physicians – This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.
CREDIT DESIGNATION
Physicians
The Potomac Center for Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For questions regarding CME/CPE credit or the evaluation, please email [email protected].
ABIM MOC DESIGNATION STATEMENT
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
For ABIM MOC points, your information will be shared with the ABIM through PCME's ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
MOC APPROVAL STATEMENT
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, "Obesity and COVID-19 in the Outpatient Setting: What Clinicians Need to Know" has met the requirements as a MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:
MOC Part II CME Activity
Family Medicine
Infectious Disease
Internal Medicine
Pediatrics
PHARMACIST ACCREDITATION STATEMENT
The Potomac Center for Medical Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
PHARMACIST CREDIT DESIGNATION
The Potomac Center for Medical Education designates this educational activity for a maximum of 1.0 contact hours (0.10 CEUs) of continuing education credit (UAN number 0418-9999-20-004-H01-P).
This is a knowledge-based activity.
NURSING CREDIT STATEMENT
This nursing continuing professional development activity was approved by the Maryland Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Available Credit
- 1.00 MOC
- 1.00 MOC II
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
This course is offered through Rockpointe. To take this course you will be redirected to Rockpointe's website. You must have an account with Rockpointe in order to complete this activity.
Mocingbird continues to work with our CME partner network to provide courses directly to you. We appreciate your patience as we work toward that goal!